Relief Therapeutics Holding AG
RLFTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $27,872 | $53,045 | $14,908 | $23,406 |
| - Cash | $12,500 | $15,080 | $10,728 | $14,556 |
| + Debt | $1,900 | $2,143 | $2,417 | $2,965 |
| Enterprise Value | $17,272 | $40,108 | $6,597 | $11,815 |
| Revenue | $1,218 | $2,763 | $5,654 | $3,010 |
| % Growth | -55.9% | -51.1% | 87.8% | – |
| Gross Profit | $619 | $1,750 | $4,092 | -$5,140 |
| % Margin | 50.8% | 63.3% | 72.4% | -170.8% |
| EBITDA | -$4,015 | -$14,040 | -$2,540 | -$6,644 |
| % Margin | -329.6% | -508.1% | -44.9% | -220.7% |
| Net Income | -$4,478 | -$12,562 | -$4,557 | -$41,682 |
| % Margin | -367.7% | -454.7% | -80.6% | -1,384.8% |
| EPS Diluted | -0.36 | -1 | -0.36 | -3.32 |
| % Growth | 64% | -177.8% | 89.2% | – |
| Operating Cash Flow | -$3,760 | $250 | -$3,166 | -$7,053 |
| Capital Expenditures | -$12 | $0 | -$172 | -$77 |
| Free Cash Flow | -$3,772 | $250 | -$3,338 | -$7,130 |